Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-09-24
DOI
https://doi.org/10.3324/haematol.2026.301466
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related

Lauren Higgins, William Carson, Gail J. Roboz, Howard Streicher et al.
Haematologica
Acute Myeloid Leukemia Research
article

Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related

Lauren Higgins, William Carson, Gail J. Roboz, Howard Streicher, Daniel T. Peters, Anastasia Ivanova, Joshua F. Zeidner, Ivana Gojo, E. Claire Dees, Richard F. Little, Leo Luznik, Kristin Koenig, Jesus Gonzalez-Lugo, Alice Mims, Emily Curran, Jiajun He, Uma Borate, Michael Hochman, Daniel Reed, Angela Nichols, Bayard Powell, Tara Lin, Christopher Hourigan, Allison McKinney
article en

Abstract

No abstract available for this paper.
Haematologica
University of North Carolina at Chapel Hill (US), Atrium Health Wake Forest Baptist (US), NewYork–Presbyterian Hospital (US), Emory University (US), Baylor College of Medicine (US), Cornell University (US), New York Hospital Queens (US), Augusta University Health (US), Presbyterian Hospital (US), The University of Kansas Cancer Center (US), Piedmont Cancer Institute (US), Sidney Kimmel Comprehensive Cancer Center (US), Weill Cornell Medicine (US), UNC Lineberger Comprehensive Cancer Center, University of Virginia (US), The Ohio State University (US), University of Cincinnati (US), Virginia Tech (US)
Good health and well-being
Openalex Percentile: Top 11%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Randomized phase II trial of liposomal cytarabine and daunorubicin with or without pomalidomide in newly diagnosed acute myeloid leukemia myelodysplasia-related — Lauren Higgins, William Carson, et al. · Haematologica (2026) | TGRS Research Map | TGRS